A new study from Juniper Research has estimated that the adoption of health monitoring devices will nearly treble by 2020, exceeding 70 million worldwide, up from an estimated 26 million this year.

The new research, Worldwide Digital Health: Developed and Emerging Market Opportunities 2016-2020, forecasts that the use of monitoring devices is set to witness a swift rise as new entrants gain FDA (Food & Drug Administration) approval. However, it highlights the need for new entrants to prove that their hardware is able to measure health indicators with the same accuracy as standard medical devices.

Paving the Way for Connected Personal Health

The research argues that greater consumer affinity with connected monitoring devices will in turn be accompanied by an upsurge in the adoption of mobile and cloud health platforms such as Apple Health and Google Fit.

Furthermore, it claims that the ‘Big Data’ collected by such monitoring devices presents a significant medium term opportunity for platforms such as IBM Watson Health Cloud. These already offer greater insight into health information and enable more efficient decision making through data analytics.

The Future of Genomics

The research also argued that with companies, such as Illumina, now mapping a large number of individuals’ genomes, healthcare providers will increasingly have access to unique sets of genomic information.
This will offer the potential for healthcare providers to offer personalised plans based on that individual’s genetic traits and susceptibility to diseases such as cancer, including treatments which have previously achieved positive results when delivered to patients with similar genomes.

Other findings from the research include:

• Heightened accuracy from the latest iteration of monitoring devices will lead to a fourfold increase in the number of individuals being monitored by 2020. Interoperability with personal smartphone devices will add further value for the patient.

• While the number of individuals using mHealth information services is expected to increase from 60 million this year to 150 million by 2020, growth is constrained by the lack of viable business models underpinning the operations in many developing markets.

THE SMALL PRINT
We hope you are enjoying the site, please note The –Boomers site has been prepared solely for information purposes. Users are advised to seek independent financial advice or in the case of health related content –consult your GP or medical professional. All information, opinions expressed on the The-Boomers are current as of the date of publication, but may become out of date over time. No liability and/or guarantee of performance is accepted or offered. The opinions expressed in The-Boomers do not constitute investment advice or health advice or any other form of advice; independent advice should be sought where appropriate. Articles are supplied strictly without accepting any liability, responsibility or duty of care for their services, content, or links to other subsequent related or unrelated material. The Site contains general information only and does not take into account the individual health issues /objectives or the individual financial situation/objectives or needs of a person or persons. Please see our Terms & Conditions for further information.